ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Disruption Of Operations At The Company'S Manufacturing Facilities At Sikkim Due To Flash Floods.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Expensive Performer

912.9500 -1.60 (-0.17%)

NSE May 16, 2025 15:31 PM

29.98% Fall from 52W High

Volume: 53,566

Alembic Pharmaceuticals Ltd.

04 Oct 2023

912.95

-0.17%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Please find enclosed the intimation for disruption of operation at the Company''s manufacturing Facility at Sikkim due to flash flood

More from Alembic Pharmaceuticals Ltd.

Recommended

Five Interesting Stocks Today - May 16, 2025

The Baseline | 16 May 2025, 06:42PM

Market closes lower, Center plans to allocate a defence budget of Rs 7 lakh crore by FY27

Trendlyne Marketwatch | 16 May 2025, 04:01PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals